Skip to main content
Premium Trial:

Request an Annual Quote

Former ABI President Hunkapiller Surfaces at VC Shop Alloy Ventures

NEW YORK, Feb. 17 (GenomeWeb News) - Former Applied Biosystems president and founder Michael Hunkapiller has landed a job as general partner at private equity firm Alloy Ventures, the company said today.

 

Hunkapiller, who left ABI in August, will focus on what Alloy calls "the intersection of the firm's interests in information technology and life sciences innovations," and "in particular [on] technologies that will help realize the potential of large scale biology projects to fundamentally change the medical and biotechnology landscape."

 

The private-equity firm said Hunkapiller will invest in companies "that take a high technology approach to addressing important unmet clinical and research needs."

 

Based in Palo Alto, Calif., Alloy has invested in genomics-related tool companies such as ZyomyxAria Biosciences, and ABI.

 

Before his stint at ABI, which spanned 1998-2004, Hunkapiller was a senior research fellow at the California Institute of Technology, where he worked with Leroy Hood on the early development of several technologies that ABI would go on to sell. He received his PhD in chemical biology from Caltech in 1974.

 

Hunkapiller is at least the second high-profile ABI or Celera alumnus to leave Applera for VC shores. Chief Business Officer Peter Barrett left Celera in January 2002 for Atlas Ventures, where he leads the company's life science investment business.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.